Skip to main content
. 2014 Oct 27;9(10):e111424. doi: 10.1371/journal.pone.0111424

Figure 8. The miRNA panel in different clinical phases in the validation set.

Figure 8

A: The corresponding AUCs for patients with preclinical phase, B: The corresponding AUCs for patients with asymptomatic phase, C: The corresponding AUCs for patients with symptomatic phase. D: The corresponding AUCs for patients with liver insufficiency phase.